Characteristics and prognosis of childhood atopic dermatitis: A multicenter study in Turkey

dc.contributor.authorYüksel, Hasan
dc.contributor.authorCan, Demet
dc.contributor.authorReisli, İsmail
dc.contributor.authorUzuner, Nevin
dc.contributor.authorOrhan, Fazıl
dc.contributor.authorCevit, Ömer
dc.contributor.authorTahan, Fulya
dc.contributor.authorKuyucu, Semanur
dc.contributor.authorBingöl, Ayşen Boz
dc.contributor.authorAkçay, Ahmet
dc.contributor.authorYılmaz, Özge
dc.contributor.buuauthorCanıtez, Yakup
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı.tr_TR
dc.contributor.scopusid8988954700tr_TR
dc.date.accessioned2022-09-07T07:06:06Z
dc.date.available2022-09-07T07:06:06Z
dc.date.issued2010
dc.description.abstractBackground: Childhood atopic dermatitis (AD) is classically accepted as initial finding of atopic march; however, non-atopic cases do not follow this course. The aim of this study was to determine the characteristics and prognosis of AD in childhood in Turkey. Methods: The study included 531 children with AD that presented to pediatric allergy departments in 11 different regions of Turkey. Age at diagnosis, total serum and inhalant-specific immunoglobulin E (IgE) levels and allergen skin prick test results were recorded retrospectively. Clinical characteristics like additional allergic diseases at presentation or during follow-up were recorded as well as duration of follow-up. Results: Mean age at diagnosis was 37.8 +/- 36.2 months. Mean IgE level was 318.3 +/- 677.8 IU/ml (median 100 IU/ml). Skin prick tests yielded positive results in 47% of children. At presentation, 31.6% of children reported additional allergic disease, while 11.7% developed allergic disease during follow-up. Among all, 46.6% had additional allergic disease at any point. IgE levels were significantly higher in children with additional allergic diseases (p = 0.001). Allergen skin prick test positivity and family history of allergic diseases increased the risk of additional allergic diseases significantly (OR = 3.90, 95% CI = 2.3-6.6 and OR = 1.89, 95% CI = 1.3-2.8, respectively). Conclusions: Allergic sensitization is not present in all cases of AD. Coexistence of additional allergic diseases is not as high as expected but more common in children who have been demonstrated to have atopic sensitization with high IgE levels and allergen skin prick test positivity.en_US
dc.identifier.citationYüksel, H. vd. (2010). "Characteristics and prognosis of childhood atopic dermatitis: A multicenter study in Turkey". International Archives of Allergy and Immunology, 152(4), 362-367.en_US
dc.identifier.endpage367tr_TR
dc.identifier.issn1018-2438
dc.identifier.issn1423-0097
dc.identifier.issue4tr_TR
dc.identifier.pubmed20197678tr_TR
dc.identifier.scopus2-s2.0-77449158879tr_TR
dc.identifier.startpage362tr_TR
dc.identifier.urihttps://doi.org/10.1159/000288289
dc.identifier.urihttps://www.karger.com/Article/Fulltext/288289
dc.identifier.urihttp://hdl.handle.net/11452/28513
dc.identifier.volume152tr_TR
dc.identifier.wos000279594800008
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalInternational Archives of Allergy and Immunologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAtopic dermatitisen_US
dc.subjectAtopic marchen_US
dc.subjectAllergyen_US
dc.subjectEczemaen_US
dc.subjectSensitizationen_US
dc.subjectAsthmaen_US
dc.subjectAssociationen_US
dc.subjectMarchen_US
dc.subjectAllergyen_US
dc.subjectImmunologyen_US
dc.subject.emtreeImmunoglobulin Een_US
dc.subject.emtreeAllergic diseaseen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeAtopic dermatitisen_US
dc.subject.emtreeChilden_US
dc.subject.emtreeChildhood diseaseen_US
dc.subject.emtreeClinical featureen_US
dc.subject.emtreeClinical trialen_US
dc.subject.emtreeComorbidityen_US
dc.subject.emtreeDisease durationen_US
dc.subject.emtreeDisease severityen_US
dc.subject.emtreeFamily historyen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFollow upen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeImmunoglobulin blood levelen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMulticenter studyen_US
dc.subject.emtreePreschool childen_US
dc.subject.emtreePrick testen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreePrognosisen_US
dc.subject.emtreeRetrospective studyen_US
dc.subject.emtreeRisk assessmenten_US
dc.subject.meshChilden_US
dc.subject.meshChild, preschoolen_US
dc.subject.meshDermatitis, atopicen_US
dc.subject.meshFemaleen_US
dc.subject.meshFollow-up studiesen_US
dc.subject.meshHumansen_US
dc.subject.meshHypersensitivityen_US
dc.subject.meshImmunoglobulin Een_US
dc.subject.meshInfanten_US
dc.subject.meshMaleen_US
dc.subject.meshPrognosisen_US
dc.subject.meshRetrospective studiesen_US
dc.subject.meshRisk factorsen_US
dc.subject.meshSkin testsen_US
dc.subject.meshTurkeyen_US
dc.subject.scopusAtopic Dermatitis; Patch Tests; Atopyen_US
dc.subject.wosAllergyen_US
dc.subject.wosImmunologyen_US
dc.titleCharacteristics and prognosis of childhood atopic dermatitis: A multicenter study in Turkeyen_US
dc.typeArticle
dc.wos.quartileQ2 (Allergyen_US
dc.wos.quartileQ3 (Immunology)en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: